Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Tax Provisions (2016 - 2025)

Historic Tax Provisions for CytomX Therapeutics (CTMX) over the last 9 years, with Q3 2025 value amounting to $58000.0.

  • CytomX Therapeutics' Tax Provisions fell 491.8% to $58000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $245000.0, marking a year-over-year decrease of 8008.13%. This contributed to the annual value of $224000.0 for FY2024, which is 9424.46% down from last year.
  • According to the latest figures from Q3 2025, CytomX Therapeutics' Tax Provisions is $58000.0, which was down 491.8% from $63000.0 recorded in Q2 2025.
  • CytomX Therapeutics' Tax Provisions' 5-year high stood at $2.8 million during Q3 2023, with a 5-year trough of $49000.0 in Q1 2024.
  • In the last 3 years, CytomX Therapeutics' Tax Provisions had a median value of $62000.0 in 2024 and averaged $477555.6.
  • Its Tax Provisions has fluctuated over the past 5 years, first crashed by 9783.92% in 2024, then soared by 2653.06% in 2025.
  • Over the past 3 years, CytomX Therapeutics' Tax Provisions (Quarter) stood at $1.1 million in 2023, then plummeted by 94.2% to $62000.0 in 2024, then dropped by 6.45% to $58000.0 in 2025.
  • Its last three reported values are $58000.0 in Q3 2025, $63000.0 for Q2 2025, and $62000.0 during Q1 2025.